接受静脉-动脉体外膜氧合患者的可改变危险因素与缺血性及出血性卒中死亡:体外生命支持组织登记研究结果
该回顾性分析基于体外生命支持组织登记库2013至2017年310个中心的数据,纳入10,342例接受单次静脉-动脉体外膜氧合支持的成人患者。其中401例(3.9%)发生缺血性卒中,229例(2.2%)发生出血性卒中;5年间报告的急性脑损伤从10%降至6%。总体住院死亡率为56%,合并缺血性卒中者死亡率为76%、合并出血性卒中者为86%。多变量分析显示低预膜氧合pH、膜氧合首日高PO2、管路机械故障和肾脏替代治疗与缺血性卒中独立相关;女性、膜氧合时长、肾脏替代治疗和溶血与出血性卒中独立相关。作者结论认为尽管急性脑损伤患病率近年下降,合并卒中时死亡率仍高,未来需研究相关危险因素的时间规律以促进预防和管理策略。
要点
- 10,342例静脉-动脉体外膜氧合成人患者中缺血性卒中401例(3.9%)、出血性卒中229例(2.2%)。
- 总体住院死亡率56%,合并缺血性卒中者76%、合并出血性卒中者86%。
- 缺血性卒中独立相关因素:低预膜氧合pH(aOR 0.21,95%CI 0.09-0.49)、膜氧合首日高PO2(aOR 1.01,95%CI 1.00-1.02)、管路机械故障(aOR 1.33,95%CI 1.02-1.74)、肾脏替代治疗(aOR 1.49,95%CI 1.14-1.94)。
- 出血性卒中独立相关因素:女性(aOR 1.61,95%CI 1.16-2.22)、膜氧合时长(aOR 1.01,95%CI 1.00-1.03)、肾脏替代治疗(aOR 1.81,95%CI 1.30-2.52)、溶血(aOR 1.87,95%CI 1.11-3.16)。
- 5年间报告的急性脑损伤从10%降至6%,但合并卒中时死亡率仍高。
适用人群与场景
- 2013至2017年向体外生命支持组织报告的、接受单次静脉-动脉体外膜氧合支持且年龄大于18岁的患者。
研究设计与关键结果
- 研究类型为回顾性分析,数据来自体外生命支持组织310个中心2013至2017年报告,共纳入10,342例接受单次静脉-动脉体外膜氧合支持的成人患者。
- 缺血性卒中401例(3.9%),出血性卒中229例(2.2%);5年间报告的急性脑损伤从10%降至6%。
- 总体住院死亡率56%,合并缺血性卒中者76%、合并出血性卒中者86%。
- 多变量分析中,低预膜氧合pH(aOR 0.21,95%CI 0.09-0.49,p<0.001)、膜氧合首日高PO2(aOR 1.01,95%CI 1.00-1.02,p=0.009)、管路机械故障(aOR 1.33,95%CI 1.02-1.74,p=0.03)、肾脏替代治疗(aOR 1.49,95%CI 1.14-1.94,p=0.004)与缺血性卒中独立相关。
- 多变量分析中,女性(aOR 1.61,95%CI 1.16-2.22,p=0.004)、膜氧合时长(aOR 1.01,95%CI 1.00-1.03,p=0.02)、肾脏替代治疗(aOR 1.81,95%CI 1.30-2.52,p<0.001)、溶血(aOR 1.87,95%CI 1.11-3.16,p=0.02)与出血性卒中独立相关。
证据类型、等级与局限
- 证据类型:回顾性分析,数据来自体外生命支持组织登记库。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为尽管近年急性脑损伤患病率下降,合并缺血性或出血性卒中时死亡率仍高。
- 作者结论认为未来需研究相关危险因素的时间规律,以促进预防和管理策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Although acute brain injury is common in patients receiving extracorporeal membrane oxygenation, little is known regarding the mechanism and predictors of ischemic and hemorrhagic stroke. We aimed to determine the risk factors and outcomes of each ischemic and hemorrhagic stroke in patients with venoarterial extracorporeal membrane oxygenation support.
DESIGN: Retrospective analysis.
SETTING: Data reported to the Extracorporeal Life Support Organization by 310 extracorporeal membrane oxygenation centers from 2013 to 2017.
PATIENTS: Patients more than 18 years old supported with a single run of venoarterial extracorporeal membrane oxygenation.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Of 10,342 venoarterial extracorporeal membrane oxygenation patients, 401 (3.9%) experienced ischemic stroke and 229 (2.2%) experienced hemorrhagic stroke. Reported acute brain injury during venoarterial extracorporeal membrane oxygenation decreased from 10% to 6% in 5 years. Overall in-hospital mortality was 56%, but rates were higher when ischemic stroke and hemorrhagic stroke were present (76% and 86%, respectively). In multivariable analysis, lower pre-extracorporeal membrane oxygenation pH (adjusted odds ratio, 0.21; 95% CI, 0.09-0.49; p < 0.001), higher PO2 on first day of extracorporeal membrane oxygenation (adjusted odds ratio, 1.01; 95% CI, 1.00-1.02; p = 0.009), higher rates of extracorporeal membrane oxygenation circuit mechanical failure (adjusted odds ratio, 1.33; 95% CI, 1.02-1.74; p = 0.03), and renal replacement therapy (adjusted odds ratio, 1.49; 95% CI, 1.14-1.94; p = 0.004) were independently associated with ischemic stroke. Female sex (adjusted odds ratio, 1.61; 95% CI, 1.16-2.22; p = 0.004), extracorporeal membrane oxygenation duration (adjusted odds ratio, 1.01; 95% CI, 1.00-1.03; p = 0.02), renal replacement therapy (adjusted odds ratio, 1.81; 95% CI, 1.30-2.52; p < 0.001), and hemolysis (adjusted odds ratio, 1.87; 95% CI, 1.11-3.16; p = 0.02) were independently associated with hemorrhagic stroke.
CONCLUSIONS: Despite a decrease in the prevalence of acute brain injury in recent years, mortality rates remain high when ischemic and hemorrhagic strokes are present. Future research is necessary on understanding the timing of associated risk factors to promote prevention and management strategy.
参考来源
- Cho SM, Canner J, Chiarini G, et al. Modifiable Risk Factors and Mortality From Ischemic and Hemorrhagic Strokes in Patients Receiving Venoarterial Extracorporeal Membrane Oxygenation: Results From the Extracorporeal Life Support Organization Registry. Crit Care Med. 2020. PMID: 32931195. doi:10.1097/CCM.0000000000004498
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。